Cart summary

You have no items in your shopping cart.

    LY2090314

    LY2090314

    Catalog Number: orb1307529

    DispatchUsually dispatched within 3-5 working days
    $ 722.00
    Catalog Numberorb1307529
    CategorySmall Molecules
    DescriptionLY2090314
    CAS Number603288-22-8
    Purity99.88%
    MW512.53
    SMILESFC=1C=C2C=3N(C=C2C4=C(C(=O)NC4=O)C=5N6C(=NC5)C=CC=C6)CCN(C(=O)N7CCCCC7)CC3C1
    FormulaC28H25FN6O3
    Biological ActivityLY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.
    NoteFor research use only
    Expiration Date12 months from date of receipt.
    • LY-2090314 [orb322182]

      ≥98%

      603288-22-8

      512.53

      C28H25FN6O3

      10 mg, 5 mg, 1 mg
    • LY2090314 [orb304055]

      [603288-22-8]

      512.5349

      C28N6O3FH25

      100 mg, 1000 mg, 250 mg
    • LY2090314 [orb1224501]

      > 98%(HPLC)

      603288-22-8

      1 g, 500 mg, 200 mg, 100 mg, 50 mg, 25 mg, 10 mg, 5 mg, 2 mg
    • LY2090314 [orb1898394]

      603288-22-8

      10 mg
    • LY2090314 [orb1898393]

      603288-22-8

      10mM x 1 ml in DMSO
    Submit a review

    Filter by Rating

      • Star
      • Star
      • Star
      • Star
      • Star
      • 5 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 4 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 3 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 2 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 1 stars